Table 5 Cost analysis of private sector
Year | Consultation costs (€) | Surgery costs (€) | AUR costs (€) | Drug costs (€) | Total costs (€) | Total budget impact (%) |
|---|---|---|---|---|---|---|
SoC: Tamsulosin monotherapy | ||||||
1 | 49,924,365 | 14,706,649 | 289,282 | 47,577,203 | 112,497,498 | - |
2 | 50,090,297 | 25,743,665 | 318,303 | 47,785,803 | 123,938,068 | - |
3 | 48,962,652 | 19,836,976 | 297,142 | 47,734,616 | 116,831,388 | - |
4 | 49,630,480 | 23,620,258 | 359,129 | 47,798,059 | 121,407,926 | - |
Tamsulosin monotherapy & gradual introduction of DUT + TAM FDC | ||||||
1 | 49,898,950 | 14,619,620 | 286,287 | 48,930,196 | 113,735,054 | - |
2 | 49,458,768 | 25,003,208 | 309,888 | 50,606,379 | 125,378,243 | - |
3 | 48,142,186 | 18,967,890 | 285,101 | 52,334,084 | 119,729,260 | - |
4 | 48,397,466 | 21,698,485 | 333,965 | 54,976,669 | 125,406,586 | - |
Budget impact | ||||||
1 | -25,415 | -87,028 | -2,995 | 1,352,994 | 1,237,555 | 1.10 |
2 | -631,529 | -740,457 | -8,415 | 2,820,575 | 1,440,175 | 1.16 |
3 | -820,467 | -869,086 | -12,042 | 4,599,467 | 2,897,873 | 2.48 |
4 | -1,233,014 | -1,921,773 | -25,163 | 7,178,610 | 3,998,659 | 3.29 |